Lecap Asset Management LTD Exelixis, Inc. Transaction History
Lecap Asset Management LTD
- $369 Billion
- Q4 2024
A detailed history of Lecap Asset Management LTD transactions in Exelixis, Inc. stock. As of the latest transaction made, Lecap Asset Management LTD holds 10,454 shares of EXEL stock, worth $384,707. This represents 0.09% of its overall portfolio holdings.
Number of Shares
10,454
Previous 12,553
16.72%
Holding current value
$384,707
Previous $326 Million
6.87%
% of portfolio
0.09%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding EXEL
# of Institutions
566Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.23 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$863 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$563 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$420 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.8B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...